Groupers Based on Multiple Dispositions, Structures

763158003 |Medicinal product (product)

(product)

900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|

• Range: <<105590001 |Substance (substance)
  • While the allowed range is broader, the |Medicinal product| combined grouper concepts based on disposition and/or structure should only use sufficiently defined grouper concepts that are descendants of 766739005 |Substance categorized by disposition (substance)| and/or primitive grouper concepts that are descendants of 312413002 |Substance categorized by structure (substance)| as attribute values.
    
    
• Cardinality: 0..*
  
  • While the allowed range is broader, the |Medicinal product| combined grouper concepts should have one or more |Has active ingredient| attributes.

Use the following pattern for the FSN if the combined grouper is comprised of two dispositions or two structural groupers; align naming and case significance with the PT as described in Section 4.1 and 4.2, respectively. The active ingredients must be in alphabetical order and separated by the word “and”.

• Product containing <Active ingredient PT> and <Active ingredient PT> (product)

For example,

• • • Product containing norepinephrine reuptake inhibitor and serotonin reuptake inhibitor (product)

Use the following pattern for the FSN if the combined grouper is comprised of one disposition and one structural grouper; align naming and case significance with the FSN for the concept with the FSN as described in Section 4.1 and 4.2, respectively.

• Product containing <Structural grouper active ingredient PT> and <Disposition grouper active ingredient PT> (product)

For example,

• • • Product containing piperazine derivative and histamine receptor antagonist (product)

Use the following pattern for the PT if the combined grouper is comprised of two dispositions or two structural groupers; align naming and case significance with the PT for the concept that is selected as the attribute value. The active ingredients must be in alphabetical order and separated by the word “and".

• <Active ingredient PT> and <Active ingredient PT>-containing product

For example,

• • • Norepinephrine reuptake inhibitor and serotonin reuptake inhibitor-containing product

Use the following pattern for the FSN if the combined grouper is comprised of one disposition and one structural grouper; align naming and case significance with the FSN for the concept that is selected as the attribute value.

• <Structural grouper active ingredient PT> and <Disposition grouper active ingredient PT>-containing product

For example,

• • • Piperazine derivative and histamine receptor antagonist-containing product

Synonyms matching the FSN are not required.